Cargando…
Real-world effectiveness of mRNA COVID-19 vaccines in the elderly during the Delta and Omicron variants: Systematic review
BACKGROUND: As of 31 December 2022, there were over 6.6 million coronavirus disease 2019 (COVID-19) deaths and over 651 million cases across 200 countries worldwide. Despite the increase in vaccinations and booster shots, COVID-19 cases and deaths continue to remain high. While the effectiveness of...
Autores principales: | Palalay, Harvey, Vyas, Riddhi, Tafuto, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421623/ https://www.ncbi.nlm.nih.gov/pubmed/37575964 http://dx.doi.org/10.13105/wjma.v11.i5.167 |
Ejemplares similares
-
Estimation of Real-World Vaccination Effectiveness of mRNA COVID-19 Vaccines against Delta and Omicron Variants in Japan
por: Kodera, Sachiko, et al.
Publicado: (2022) -
Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variants
por: Hu, Qidong, et al.
Publicado: (2022) -
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
por: Tseng, Hung Fu, et al.
Publicado: (2022) -
Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022) -
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
por: Lu, Changrui, et al.
Publicado: (2023)